|
Christian Hansen, born in 1966, is co-founder and partner of Nordic Biotech. Dr. Hansen has a background as a biotech entrepreneur, biotech intellectual property rights expert and business development executive, combined with a scientific career. He has been actively involved in biotech investment since the late 1990’s.
From 2000 to 2001 Dr. Hansen was President of Maxygen's Protein Pharma Division, and Managing Director of its Danish subsidiary Maxygen ApS, employing about 75 people. From 1999 to 2000, Dr. Hansen was CEO and founder of ProFound Pharma A/S, a Danish start-up company focused on developing 2nd generation protein pharmaceuticals. The company was sold to Maxygen, Inc. one year after inception for stock worth about USD 75 mill.
From 1992 to 1999, Dr. Hansen held executive positions at Novo Nordisk A/S, including as Director of Intellectual Property Strategy, which is one of his core areas of expertise. In this capacity, Dr. Hansen was responsible for numerous patent, license and collaborative agreement strategies and negotiations, and was a member of Research Management.
Dr. Hansen holds an MSc (1989) in chemical engineering, a PhD (1992) in molecular biology/biochemistry and an MBA.
Dr. Hansen is listed as inventor in connection with more than 15 patent applications.
|
